"High Efficient, Single-Use-Bioreactor simulating mammalian tissue conditions for expression and proliferation"
(HESUB)
Start date: May 1, 2013,
End date: Apr 30, 2016
PROJECT
FINISHED
A unique combination of earlier EU funded projects allow four research SME´s to create a combined most visionary and innovative product for improved health. There is a strategic decision from pharmaceutical companies and hospitals for:1. continues expressing of biologicals to fulfill the expectation to “personalized medicine” and 2. proliferation of cells to support therapeutic applications and 3. proliferation of stem cells to prepare manufacturing of real “human spareparts”. Advanced process control inside tailor made and cell harboring scaffolds integrated in a High-Efficient-Single-Use-Bioreactor simulating mammalian tissue conditions will fulfill this requirements
Get Access to the 1st Network for European Cooperation
Log In
or
Create an account
to see this content
Coordinator
KUNGLIGA TEKNISKA HOEGSKOLAN
€ 1 291 458,00- åke Eriksson
- BRINELLVAGEN 8 100 44 STOCKHOLM (Sweden)
Details
- 75.8% € 5 752 150,00
-
FP7-HEALTH
- Project on CORDIS Platform
4 Partners Participants
PRESENS PRECISION SENSING GMBH
€ 922 000,00- Christian Krause
- Josef Engert Strasse 9 93053 Regensburg (Germany)
THE ELECTROSPINNING COMPANY LTD
€ 844 042,00- Robert Mckean
- WATERMARK WAY 10 SG13 7TZ HERTFORD (United Kingdom)
3H BIOMEDICAL AB
€ 898 850,00- Mallen Huang
- DAG HAMMARSKJOLDS VAG 34A 751 83 UPPSALA (Sweden)
STOBBE TECH AS
€ 1 795 800,00- Flemming Petersen
- MALMMOSEVEJ 19c 2840 HOLTE (Denmark)